Subscribe Now
  • Home
  • Latest
    • News
    • North America
    • Europe
    • Asia
    • Middle East
    • Global
  • Fortune 500
    • Fortune 500 U.S.
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
  • Finance
    • Economy
    • Banking
    • Personal Finance
    • Investing
    • Real Estate
    • Energy
    • Crypto
  • Tech
    • Big Tech
    • Startups & Venture
    • AI
    • Innovation
    • Cybersecurity
  • Leadership
    • Future Of Work
    • Success
    • C-Suite
    • Workplace Culture
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Health
    • Travel & Leisure
    • Education
  • Rankings
    • Great Place To Work
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Press Releases
    • Video
    • Podcasts
  • Home
  • Latest
    • Latest
    • News
    • North America
    • Europe
    • Asia
    • Middle East
    • Global
  • Fortune 500
    • Fortune 500
    • Fortune 500 U.S.
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
  • Finance
    • Finance
    • Economy
    • Banking
    • Personal Finance
    • Investing
    • Real Estate
    • Energy
    • Crypto
  • Tech
    • Tech
    • Big Tech
    • Startups & Venture
    • AI
    • Innovation
    • Cybersecurity
  • Leadership
    • Leadership
    • Future Of Work
    • Success
    • C-Suite
    • Workplace Culture
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Health
    • Travel & Leisure
    • Education
  • Rankings
    • Rankings
    • Great Place To Work
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Press Releases
    • Video
    • Podcasts
  1. home
  1. home
  2. Biotech

Biotech

Page 18 of 19

Inside of a Gilead Sciences Lab
Tech

Is the future of pharma about making good drugs great?

By Laura Lorenzetti
February 27, 2015
Bristol Myers
Finance

Flexus goes from zero to $1.25 billion in 17 months

By Dan Primack
February 24, 2015
Third Rock Ventures: Giving birth to a new generation of biotechs
Tech

Third Rock Ventures: Giving birth to a new generation of biotechs

By Jennifer Alsever
February 19, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
Finance

After Allergan loss, is Valeant dumpster diving?

By Jen Wieczner
January 31, 2015
A powerful new super antibiotic may be right under our feet

A powerful new super antibiotic may be right under our feet

By Laura Lorenzetti
January 8, 2015
The $3 billion startup that wants to help you to make medicines in your own body

The $3 billion startup that wants to help you to make medicines in your own body

By Dan Primack
January 8, 2015
Davos World Economic Forum (WEF) 2011
Leadership

Sean Parker gives $24 million to Stanford to cure allergies

By Jen Wieczner
December 17, 2014
2015 Investor’s Guide: Don’t buy this, buy that—Technology and Biotech
Finance

2015 Investor’s Guide: Don’t buy this, buy that—Technology and Biotech

By Jen Wieczner and Lauren Silva Laughlin
December 4, 2014
Daniel Loeb urges Amgen to split into two companies
Finance

Daniel Loeb urges Amgen to split into two companies

By Reuters
October 21, 2014
Michelle Dipp, CEO Of OvaScience
MPW

OvaScience CEO talks Apple, Facebook and the $9 billion fertility market

By Matt McCue
October 16, 2014
How to stop Ebola
Features

How to stop Ebola

By Erika Fry
September 4, 2014
Catalent delivers with $871 million biotech IPO
Finance

Catalent delivers with $871 million biotech IPO

By Laura Lorenzetti
July 31, 2014
Wall Street’s next bet: Cures for rare diseases
Features

Wall Street’s next bet: Cures for rare diseases

By Andrew W. Lo
January 21, 2014
The big bull backup
Features

The big bull backup

By Anne VanderMey
September 19, 2013
Fortune
Finance

Lessons from the frontlines of early-stage biotech investing

By Fortune Editors
February 12, 2013

Most Popular

  • Commentary
    Yes, you're getting a bigger tax refund. Your kids won't thank you for the $3 trillion it's adding to the deficit
    By Daniel Bunn
  • Success
    Despite running $75 billion automaker General Motors, CEO Mary Barra still responds to ‘every single letter’ she gets...
    By Preston Fore
  • Economy
    An unusual Fed ‘rate check’ triggered a free fall in the U.S. dollar and investors are fleeing into gold
    By Jim Edwards
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • MPW
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms of Use
  • Single Issues for Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work at Fortune
  • Diversity and Inclusion
  • Terms and Conditions
  • Site Map

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.